Pramlintide
Extension Study of Protocol DFA102 to Examine the Long-Term Safety, Tolerability, and Effect on Body Weight of Pramlintide Administered in Combination With Metreleptin
AstraZeneca · Phase 2 · Completed · Enrollment 274
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| 1 | n/r | n/r | n/r | n/r |
| 2 | n/r | n/r | n/r | n/r |
| 3 | n/r | n/r | n/r | n/r |
| 4 | n/r | n/r | n/r | n/r |
Not shown
- 1: endpoint not reported
- 2: endpoint not reported
- 3: endpoint not reported
- 4: endpoint not reported